On Feb. 7, CMS posted a notice that it will begin accepting registrations for Sunshine Act aggregate-spending reports from industry on Feb. 18. Agg-spend reporting obliges the life sciences industries and GPOs to report payments offered to physicians. Additional data elements will be accepted in May, and all data will be made public later this year. Details at http://content.govdelivery.com/accounts/USCMS/bulletins/a3f695?reqfrom=share.
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
July 2nd 2025As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.